Section 01
What It Actually Is
CJC-1295 / Ipamorelin is a combination of two peptides that work synergistically to stimulate your body's natural growth hormone (GH) production. CJC-1295 is a growth hormone-releasing hormone (GHRH) analog that extends the GH release window. Ipamorelin is a growth hormone secretagogue that triggers a clean GH pulse without spiking cortisol or prolactin.
Together, they amplify and sustain the pulsatile release of GH from the anterior pituitary, mimicking your body's natural rhythm rather than replacing it.
~30 min
Ipamorelin half-life
2β4Γ
GH pulse amplification
90 days
Minimum protocol
β οΈWhat this stack is NOT
This is not synthetic HGH. It does not inject growth hormone directly. It stimulates your pituitary to produce more of its own GH. If your pituitary function is severely compromised, this stack may not be effective. It is also not a fat burner, muscle builder, or anti-aging miracle, though patients report improvements in all three areas over time with physician oversight.
Section 02
Who It's Actually For
The most common patient profiles we see fall into four categories. A physician will evaluate your specific health history before prescribing.
| Feature | CJC-1295 (no DAC) | CJC-1295 DAC | Ipamorelin | Combined Stack |
|---|---|---|---|---|
| Half-life | ~30 min | ~8 days | ~30 min | Synergistic |
| Injection Frequency | 1β2Γ daily | 1β2Γ weekly | 1β2Γ daily | 1β2Γ daily |
| GH Pulse Quality | Pulsatile | Sustained | Clean | Excellent |
| Side Effects | Minimal | GH bleed risk | Minimal | Minimal |
| Most Common Use | Clinical | Convenience | Clinical | Gold standard |
Feature
CJC-1295 (no DAC)
CJC-1295 DAC
Ipamorelin
Combined Stack
Feature
CJC-1295 (no DAC)
CJC-1295 DAC
Ipamorelin
Combined Stack
Feature
CJC-1295 (no DAC)
CJC-1295 DAC
Ipamorelin
Combined Stack
Feature
CJC-1295 (no DAC)
CJC-1295 DAC
Ipamorelin
Combined Stack
Feature
CJC-1295 (no DAC)
CJC-1295 DAC
Ipamorelin
Combined Stack
| Patient Profile | Primary Goal | Typical Age | Fit |
|---|---|---|---|
| Age-related GH decline | Body composition, energy, and sleep | 35β60 | Excellent |
| Athletic recovery | Faster tissue repair and deeper sleep | 28β50 | Good |
| Metabolic optimization | Fat loss and insulin sensitivity | 30β55 | Good |
| Post-menopausal women | Body composition and bone density support | 45β65 | Underserved |
Patient Profile
Primary Goal
Typical Age
Fit
Patient Profile
Primary Goal
Typical Age
Fit
Patient Profile
Primary Goal
Typical Age
Fit
Patient Profile
Primary Goal
Typical Age
Fit
π¬Women are underserved in peptide therapy
Most peptide research has been conducted on male subjects. However, women, particularly post-menopausal women, may benefit significantly from GH optimization for body composition, bone density, and sleep quality. A physician can assess whether this protocol is appropriate for your specific hormonal profile.
β οΈDAC confusion can be dangerous
CJC-1295 with DAC and without DAC have drastically different dosing schedules and pharmacokinetics. Confusing the two can lead to sustained GH elevation (GH "bleed") which mimics some risks of exogenous HGH. Always confirm which version your protocol uses.
Section 03
How It Works
The key to understanding this stack is the concept of pulsatility. Your body doesn't release growth hormone in a steady stream. Instead, it releases it in discrete pulses, primarily during deep sleep. This stack amplifies those natural pulses rather than creating an artificial, constant GH elevation.
π§¬Pulsatility: why it matters
Continuous GH elevation (as seen with exogenous HGH or CJC-1295 with DAC) can downregulate GH receptors over time. Pulsatile release, the kind CJC-1295 (no DAC) + Ipamorelin produces, preserves receptor sensitivity and mimics the body's natural secretion pattern. This is why the no-DAC version is preferred in most clinical protocols.
βοΈWhy Ipamorelin over GHRP-6 or GHRP-2?
Older secretagogues like GHRP-6 and GHRP-2 trigger GH release but also spike cortisol, prolactin, and hunger via ghrelin receptor activation. Ipamorelin is selective: it stimulates GH release without these side effects, making it the cleanest secretagogue available and the reason it's paired with CJC-1295 in modern protocols.
Section 04
Realistic Expectations
One of the biggest sources of frustration with peptide therapy is unrealistic timelines. Here's what the clinical literature and patient reports actually suggest:
Week 1
Week 4
Week 8
Week 12
Month 6
πThe evidence gap
Most published data on CJC-1295/Ipamorelin comes from small studies and clinical observations, not large-scale randomized controlled trials. The timelines above reflect a combination of published literature and aggregated patient reports, not guaranteed outcomes. Your physician will set expectations based on your specific health profile.
πWhat happens when you stop
CJC-1295/Ipamorelin stimulates your own GH production; it doesn't replace it. When you discontinue, your GH levels return to baseline over 2 to 4 weeks. There is no "crash" or withdrawal. However, the benefits that depended on elevated GH (sleep quality, body composition maintenance) will gradually diminish without ongoing protocol support.
Section 05
Dosing Protocol
The most common source of confusion (and error) in peptide therapy is the units-to-mcg translation. Here's the standard VitalRx protocol, broken down clearly.
Month 1: Titration
10 units = 0.1 mL = 100 mcg each
100 mcg CJC-1295 + 100 mcg Ipamorelin per injection. One injection nightly, 5 nights per week.
Draw to the 10-unit mark on a U-100 insulin syringe
Month 2+: Full Dose
20 units = 0.2 mL = 200 mcg each
200 mcg CJC-1295 + 200 mcg Ipamorelin per injection. One injection nightly, 5 nights per week.
Draw to the 20-unit mark on a U-100 insulin syringe
| Parameter | Month 1 | Month 2+ |
|---|---|---|
| Dose per peptide | 100 mcg | 200 mcg |
| Syringe draw | 10 units (0.1 mL) | 20 units (0.2 mL) |
| Frequency | 5 nights/week | 5 nights/week |
| Timing | 30 min before bed | 30 min before bed |
| Injection site | Subcutaneous (abdomen) | Subcutaneous (abdomen) |
Parameter
Month 1
Month 2+
Parameter
Month 1
Month 2+
Parameter
Month 1
Month 2+
Parameter
Month 1
Month 2+
Parameter
Month 1
Month 2+
π«Never double a missed dose
This is one of the most dangerous mistakes we see in online forums. Doubling up does not "make up" for a missed injection. It risks an unnaturally large GH spike that can cause headaches, water retention, and joint pain. If you miss a dose, simply resume your normal schedule the next evening.
πVitalRx: pre-constituted eliminates math error
VitalRx ships pre-constituted vials from our 503B pharmacy. You don't need to reconstitute lyophilized powder, calculate bacteriostatic water ratios, or do any unit math. Draw to the mark your physician specifies. That's it.
Section 06
Cycling: Evidence vs. Myth
"Do I need to cycle CJC/Ipamorelin?" is one of the most common questions. Here's what the evidence actually says:
| Claim | Source | Evidence Level |
|---|---|---|
| Must cycle 8 weeks on / 4 off | Forum consensus | No human RCT |
| 5-on / 2-off prevents desensitization | Clinical practice | Theoretical |
| Continuous use causes receptor downregulation | GHRP-6 extrapolation | Indirect |
| No cycling needed for no-DAC CJC-1295 | Pharmacokinetic rationale | Plausible |
| Annual cycling (3 months on, 1 month off) | Physician preference | Common practice |
Claim
Source
Evidence Level
Claim
Source
Evidence Level
Claim
Source
Evidence Level
Claim
Source
Evidence Level
Claim
Source
Evidence Level
πThe honest answer
There are no published human randomized controlled trials specifically studying cycling protocols for CJC-1295/Ipamorelin. The 5-on/2-off schedule used by most clinics (including VitalRx) is based on pharmacokinetic reasoning and clinical experience, not hard evidence. Your physician will recommend a cycling approach based on your response to therapy.
Section 07
Ready to Inject
The quality of what you're injecting matters more than anything else in your protocol. Here's how VitalRx approaches preparation and delivery.
0
Mixing steps required
503B
Pharmacy standard
2β8Β°C
Cold-chain shipping
π¦Cold-chain + pre-constituted
VitalRx ships pre-constituted peptides from a 503B outsourcing facility in temperature-controlled packaging. This eliminates reconstitution errors, the #1 source of dosing inaccuracy in at-home peptide therapy. Your vials arrive ready to draw and inject.
β οΈGray-market purity: the data is ugly
Independent testing of research-grade peptides purchased online has consistently shown alarming results. A 2023 analysis found that only 4.3 out of 10 samples from popular gray-market sources contained the labeled amount of active peptide within acceptable variance. Contaminants, under-dosing, and mislabeling are the norm, not the exception.
Section 08
Getting the Most From Your Protocol
The peptide itself is only part of the equation. These evidence-informed habits can meaningfully impact your results:
Timing
Bedtime Alignment
Inject 30 min before sleep
Nutrition
Fasted Injection Window
2+ hours after last meal
Avoidance
GH Suppressors
No alcohol or high-glycemic food
Schedule
5-On / 2-Off Rationale
Receptor sensitivity preservation
Recovery
Sleep Architecture
Prioritize sleep hygiene
Mindset
The 90-Day Rule
Minimum commitment period
Section 09
Stacking
Stacking refers to combining CJC-1295/Ipamorelin with other peptides or compounds. Some combinations are well-supported; others carry meaningful risk.
Pairs Well With
- BPC-157β Tissue repair and gut healing. Complementary mechanism, no known interaction.
- Thymosin Beta-4 (TB-500)β Systemic tissue repair. Often paired in recovery-focused protocols.
- MOTS-Cβ Mitochondrial peptide. Targets metabolic function via different pathway.
- NAD+ therapyβ Cellular energy. Different mechanism entirely; no competitive interaction.
Approach with Caution
- MK-677 (Ibutamoren)β Oral GH secretagogue. Can cause sustained GH elevation and insulin resistance with CJC/Ipa.
- GHRP-6 / GHRP-2β Redundant mechanism with more side effects. Cortisol and prolactin spikes.
- Exogenous HGHβ Combining with GH secretagogues can cause supraphysiologic GH levels. Physician assessment required.
- Multiple GH-axis compoundsβ Stacking 3+ GH-targeting compounds increases unpredictability without proportional benefit.
β οΈCommunity stacking behavior
Online forums frequently recommend aggressive multi-peptide stacks without acknowledging that interaction data between most peptide combinations simply doesn't exist. Physician oversight is especially important when combining compounds, not because we're gatekeeping, but because the safety data isn't there yet.
Section 10
Pricing Comparison
Peptide therapy pricing is notoriously opaque. Here's an honest comparison:
| Source | Monthly Cost | Physician | Pharmacy Grade | Purity Verified |
|---|---|---|---|---|
| Other telehealth clinics | $250β$450/mo | Yes | Yes | Varies |
| VitalRx, Month 1 | $199 | Yes | 503B | CoA included |
| VitalRx, Month 2+ | $229/mo | Yes | 503B | CoA included |
| Gray market (research-grade) | $40β$80/mo | No | No | No |
Source
Monthly Cost
Physician
Pharmacy Grade
Purity Verified
Source
Monthly Cost
Physician
Pharmacy Grade
Purity Verified
Source
Monthly Cost
Physician
Pharmacy Grade
Purity Verified
Source
Monthly Cost
Physician
Pharmacy Grade
Purity Verified
Included
Medication
Pre-constituted CJC-1295 + Ipamorelin from a 503B pharmacy. Ready to inject.
Included
Physician Oversight
Board-certified physician review, prescription, and ongoing protocol support.
Included
No Lab Requirement
We don't require labs to start. Your physician may recommend them based on your health profile.
Included
Supplies + Shipping
Syringes, alcohol wipes, and cold-chain shipping included. No hidden fees.
π°The number clinics hide
Many telehealth peptide clinics advertise low consultation fees but charge separately for the medication, shipping, supplies, and follow-up visits. Always ask for the all-in monthly cost. VitalRx's price includes everything: medication, physician oversight, supplies, and shipping.
πWhy Month 1 is priced lower
Month 1 uses a titration dose (100 mcg vs. 200 mcg). Less medication = lower cost. We pass that savings to you rather than charging the same price for half the dose. It's that simple.
Section 11
Legal Access in All 50 States
The regulatory landscape for peptides is complex and evolving. Here's the current status:
503B
Outsourcing facility
Physician Rx
Required for access
Off-Label
Legal & standard
Under Review
Reclassification pending
CJC-1295 and Ipamorelin are currently available through the 503B compounding pathway β federally-regulated outsourcing facilities that compound medications under FDA oversight. This pathway exists specifically for medications that are not commercially available in finished dosage form.
In 2023, the FDA began reviewing certain peptides for potential reclassification. As of this writing, CJC-1295 and Ipamorelin remain available through the 503B pathway, but the regulatory environment is actively evolving. VitalRx monitors these changes in real time and will communicate any impacts to active patients.
Off-label prescribing is a standard, legal practice in U.S. medicine. Approximately 20% of all prescriptions in the U.S. are written off-label. Your physician will explain the regulatory status and evidence base for your specific protocol during your consultation.
β6 common misconceptions
| Misconception | Reality |
|---|---|
| Peptides are illegal | Prescription peptides from 503B pharmacies are legal in all 50 states |
| You need a special license to buy them | You need a physician's prescription β that's it |
| The FDA has banned peptides | The FDA is reviewing some peptides for reclassification, not banning |
| Research-grade is the same as pharmacy-grade | Research-grade is unregulated. 503B pharmacy-grade is federally overseen |
| Telehealth prescriptions aren't real prescriptions | Telehealth prescriptions carry the same legal weight as in-person Rx |
| Peptides are only available in certain states | 503B pharmacy + licensed physician = available in all 50 states |
Misconception
Reality
Misconception
Reality
Misconception
Reality
Misconception
Reality
Misconception
Reality
Misconception
Reality
π₯The 503B pathway explained
A 503B outsourcing facility is an FDA-registered facility that compounds medications without individual patient prescriptions, meaning they can prepare medications in bulk under federal oversight. This is the same regulatory framework used for compounded IV medications in hospitals. VitalRx sources exclusively from 503B facilities, not 503A (traditional compounding pharmacies) or research chemical suppliers.
Section 12
Community Q&A
These are real questions we see repeatedly in patient communities. We've answered them with the same transparency we bring to the rest of this guide.
Section 13
The VitalRx Model
Everything above describes why trust matters. Here's how VitalRx is built to earn it:
503B Sourcing
Pre-Constituted Cold Chain
Physician Oversight
One Price, All 50 States
Ready for physician-supervised peptide therapy?
Start with a free health profile. A licensed physician will review your intake and recommend a protocol built around your goals.
Get Your Free Consultation βNo subscription required Β· Cancel anytime Β· All 50 states